# US FDA approves GSK hepatitis B drug, offering an option after long-term treatment

https://mins.news/en/item/108554

- Reuters, 2026-10-20 21:35 UTC
- Health
- Original: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-gsks-hepatitis-b-drug-offering-patients-chance-stop-long-term-2026-10-20/?link_source=ta_bluesky_link&taid=6ad7de8cab53aa0001d9b5c9

> The US Food and Drug Administration approved British drugmaker GSK’s hepatitis B drug Hibsago on Tuesday. It gives people with the liver infection a way to keep the virus under control after stopping treatment.